Onyx Pharmaceuticals Reschedules Its Third Quarter 2012 Conference Call to November 1, 2012 at 1:30 PM ET
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/29/12 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it has rescheduled its third quarter 2012 financial report and conference call due to Hurricane Sandy. Onyx will report financial results for the third quarter ended September 30, 2012 after market closes on Thursday, November 1, 2012 and will host a conference call and webcast with management to discuss financial results, as well as provide a general business overview, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
To access a live audio webcast of the conference call, log onto the company's website at:
To access the live conference call, dial 847-585-4405 and use the passcode 33476074#. A replay of the call will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 33476074# approximately one hour after the teleconference concludes through November 15, 2012.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.10.2012 - 15:43 Uhr
Sprache: Deutsch
News-ID 1164952
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SOUTH SAN FRANCISCO, CA
Phone:
Kategorie:
Surgery & Treatments
Anmerkungen:
Diese Pressemitteilung wurde bisher 191 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Onyx Pharmaceuticals Reschedules Its Third Quarter 2012 Conference Call to November 1, 2012 at 1:30 PM ET
"
steht unter der journalistisch-redaktionellen Verantwortung von
Onyx Pharmaceuticals, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
